Swedish Orphan Biovitrum AB (Sobi)

Swedish Orphan Biovitrum AB (Sobi) - Stockholm, Sweden; originally Kabivitrum AB, then Pharmacia & Upjohn AB, then Pharmacia Corp., with most facilities and lines of business spun-off to Biovitrum AB in 2001, now named Swedish Orphan Biovitrum AB (Sobi); Octapharma AG acquired the plasma products division of Biovitrum in July 2002

Related product monographs:

1. C1-esterase inhibitor, rDNA -- Europe mark.
2. Factor IX, rDNA/Pfizer -- Europe mark.
3. Factor VIII, rDNA, old/Wyeth -- Manuf. ; R&D ; Tech. ; Europe mark.
4. Factor VIII, rDNA, new/Wyeth -- Manuf. ; R&D ; Tech.
5. Interleukin-1ra, rDNA -- World mark. ; Europe mark.
6. Keratinocyte growth factor, rDNA -- World mark.
7. Somatropin, rDNA/Pfizer -- Manuf. ; Tech.
8. Streptokinase/Octapharma -- Former
9. Antithrombin III/Octapharma -- Former

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute